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Gramicidin, an antimicrobial peptide active against Gram positive bacteria, is commonly used in 
pharmaceutical preparations for topical use. Considering that only the turbidimetric method has been 
described in the literature, the present study sought to develop and validate an agar diffusion method for 
the dosage of gramicidin. The method was developed and validated using the Kocuria rhizophila ATCC 
9341 as a test microorganism. Two designs were used: a 3x3 parallel-line model, and a 5x1 standard curve. 
The validation demonstrated that the method follows the linear model (r2= 0.994), presenting a significant 
regression between the zone diameter of growth inhibition and the logarithm of the concentration within 
the range of 5 to 25.3 μg/mL. The results obtained for both designs were precise, having a relative standard 
deviation (R.S.D.) for intra-day precision of 0.81 for the 3x3 assay and 1.90 for the 5x1 assay. For the 
inter-day precision, the R.S.D. was 1.35 for the 3x3 and 2.64 for the 5x1. The accuracy was verified and 
results confirmed to be accurate, having a tolerance interval of 95%, which lay within permitted limits 
and appropriate trueness. In addition, the method was considered selective, with limit of detection and 
upper and lower limits of quantification of 2.00, 5.00 and 25.3 μg/mL, respectively. No difference in 
precision between the designs used in the agar diffusion method was evident  (p>0.05). The method 
proved to be appropriate for the microbiological dosage of the raw material gramicidin.
Uniterms: Gramicidin/microbiological assay. Microbiological assay/method validation. Agar diffusion. 
Cylinder-plate.
A gramicidina, um peptídeo antimicrobiano ativo contra bactérias Gram positivo, é utilizada em 
preparações farmacêuticas de uso tópico. Neste trabalho procurou-se desenvolver e validar outro método 
para o doseamento de gramicidina tendo em vista que somente o método turbidimétrico é descrito. O 
método de difusão em ágar foi desenvolvido e validado utilizando como microrganismo teste Kocuria 
rhizophila ATCC 9341. Foram utilizados dois delineamentos: retas paralelas 3x3 e curva padrão 5x1. A 
validação demonstrou que o método segue o modelo linear (r2= 0,994) havendo regressão significativa 
entre o diâmetro dos halos de inibição e o logaritmo da concentração na faixa de 5,00 a 25,3 µg/mL. 
Os resultados obtidos por ambos os delineamentos foram precisos apresentando desvio padrão relativo 
(DPR) para precisão intra-dia de 0,81 para ensaio 3x3 e de 1,90 para ensaio 5x1. Para a precisão inter-
dias o DPR foi de 1,35 para 3x3 e de 2,64 para 5x1. A exatidão foi verificada e os resultados foram 
exatos apresentando intervalo de tolerância a 95% dentro dos limites permitidos e veracidade adequada. 
O método foi seletivo com limites de detecção e quantificação inferior e superior iguais a 2,00, 5,00 e  
25,3 µg/mL, respectivamente. Não foi observada diferença entre a precisão dos delineamentos empregados 
no método de difusão em ágar (p>0.05). O método se mostrou adequado para a dosagem microbiológica 
de gramicidina matéria-prima.
Unitermos: Gramicidina/doseamento microbiológico. Doseamento microbiológico/validação de método. 
Difusão em Agar. Cilindros em placa.
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INTRODUCTION
Gramicidin is a neutral linear pentadecapeptide 
present in the antimicrobial mixture tyrothricin (grami-
cidin + tyrocidine), produced by Bacillus brevis. Isolated 
gramicidin acts against Gram positive bacteria, forming 
canals specifically for monovalent metals and ammonium 
cations in cell membrane, thus increasing its permeability 
(Koo et al., 2001).
This material is used in pharmaceutical forms for 
isolated topical use, or in combination with other antibiot-
ics for the treatment of bacterial infections (Bosscha et al., 
2004; Zaias et al., 1981).
Previous studies in the  literature have reported 
on the turbidimetric method for determining the ac-
tivity of the raw material gramicidin (United States 
Pharmacopoeia, 2008; British Pharmacopoeia, 2007). 
However, in practice, this method has proven to be inef-
fective and relatively susceptible to variations, thus lead-
ing to non-repeatable results and to the need for several 
repetitions.
In 1958, Vuilleumier and Anker developed the agar 
diffusion method to determine the potency of tyrothricin, 
but this method called for a long period of pre-diffusion 
of approximately 8 hours, yet only small zone diameters 
could be obtained (Vuilleumier, Anker, 1958). This meth-
od was modified by Viola and Canestrini in 1966 who, to 
obtain larger zone diameters, increased the pre-diffusion 
time even more (20 hours). These methods, used to deter-
mine the proper potency of tyrothricin, proved to be un-
suitable for normal laboratory routines, considering that 
they demanded an extensive time period for execution 
and were never validated because no such procedures 
were required at the time. After 1966, no other informa-
tion regarding the dosage of tyrothricin or gramicidin can 
be found.
Against this background, the present study set out 
to develop an agar diffusion method for determining the 
dosage of the raw material gramicidin and to validate it by 
means of parameters of selectivity, accuracy, calibration 
curve, precision, robustness, and detection and quantifi-
cation limits (Hubert et al., 2007a,b; Rozet et al., 2007a; 
Brasil, 2003; FDA, 2001; ICH, 1996).
MATERIALS AND METHODS
Raw material and reference standard
Gramicidin – substance of reference (Sigma-Aldri-
ch, potency 960 μg/mg) and raw material (Alpharma).
Reagents and solvents
Sodium Chloride (Synth), dibasic potassium phos-
phate (Synth), monobasic potassium phosphate (Synth), 
ethyl alcohol (Synth), methanol (Merck), polysorbate 80 
(Synth), meat extract (Prodimol), yeast extract (Prodimol), 
tryptone (Oxoid), glucose (CRQ), lactalbumin (Difco), 
casamine (Difco), and agar (Difco).
Microorganisms and inoculums
The cultures of Kocuria rhizophila ATCC 9341, 
Staphylococcus aureus ATCC 6538, Staphylococcus epi-
dermidis ATCC 12228, and Enterococcus hirae ATCC 
10541 were supplied by the Brazilian National Health and 
Quality Control (INCQS, RJ, Brazil), cultivated in antibio-
tic medium 1 and maintained in a refrigerator (4 ± 2 ºC). 
Twenty-four hours before the assay, a new pealing was 
performed to obtain the inoculum at 1.0 ± 0.1 of absor-
bance, at 580 nm in a 0.9% sodium chloride solution. To 
select the test microorganism, 0.5 and 0.25 mL of this sus-
pension were added to 100 mL of antibiotic medium 1 at 
47 ± 2 ºC, which was used as an inoculated layer. For the 
dosage of gramicidin, the surface layer consisted of inocu-
lated nutrient agar with K. rhizophila (inoculum at 0.1%).
Culture media and solutions used
Antibiotic medium 1 (Difco), nutrient agar (Prodi-
mol – 5 g of gelatin peptone, 3 g of meat extract, 5 g of 
yeast extract, 5 g of glucose, 15 g of agar in 1000 mL of 
water), 7.0 pH buffer (13.6 g of dibasic potassium phos-
phate and 4.0 g of monobasic potassium phosphate in 
1000 mL of water) were used.
Determination of assay conditions
To determine the assay conditions, plates with two 
layers of antibiotic medium 1 were used: one non-inoculated 
(21 mL) and the other containing 4 mL of inoculated an-
tibiotic medium 1 at 0.5% and 0.25%, with the different 
microorganisms. Four stainless steel cylinders, measuring 
8 x 6 x 10 mm, were placed on the surface of the inoculated 
medium and filled with 200 μL of the gramicidin solutions 
at 2.00, 4.00, 8.00, and 16.0 μg/mL prepared in a 7.0 pH 
buffer. The plates were left for 1 hour at room temperature 
and then incubated at 36.5 ºC for 18 hours. Different diluents 
were tested to prepare the gramicidin solutions, including 
ethyl alcohol at 95%; acetone; 7.0 pH buffer, containing 
polysorbate 80 at 0.1% and 1%; and an aqueous solution of 
polysorbate 80 at 1%. Other assays using the nutrient agar as 
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a culture medium were also performed. Different ranges of 
gramicidin concentrations that lay within the 5.00 to 100 μg/
mL interval were also tested. The assessment of the assayed 
conditions was carried out by comparing the sharpness and 
the zone diameter of growth inhibition obtained.
Dosage of gramicidin using nutrient agar
Two layers of agar were used, with one non-
inoculated layer containing 21 mL of nutrient agar (base 
medium) and the other containing 4 mL of inoculated 
nutrient agar at 0.1%. Six stainless steel cylinders, mea-
suring 8 x 6 x 10 mm, were placed on the surface of the 
inoculated medium. For the 3x3 design, three alternating 
cylinders were filled with 200 μL of standard solutions 
(three concentrations), while the other three were filled 
with the sample solutions (three concentrations). Five 
assays were performed each using eight plates. For the 
5x1 design, three cylinders were filled with 200 μL of the 
reference solution (concentration of11.3 μg/mL), while 
the other three were filled with either the standard solu-
tion (concentrations of 5.00, 7.50, 16.9, or 25.3 μg/mL) 
or the sample solution (11.3 μg/mL). In each assay, three 
plates per concentration were prepared, except for that of 
the reference solution. Five assays were also performed. 
All plates were left for 1 hour at room temperature and 
then incubated at 36.5 ºC for 18 hours.
Standard solution preparation
Exactly 25 mg of reference standard gramicidin 
was weighed and transferred to a volumetric flask of 25 
mL and dissolved in ethyl alcohol at 95% (concentration 
of 1000 μg/mL). Aliquots of the solution were diluted in 
polysorbate 80 at 1% to obtain the concentrations of 5.00, 
7.50, 11.3, 16.9, and 25.3 μg/mL used in the 5x1 design, 
whereas 5.00, 10.0, and 20.0 μg/mL were used in the 3x3 
design.
Sample preparation
The raw material sample was prepared by the same 
procedure used for the reference standard.
Method validation
The method was validated by determining the pa-
rameters of calibration curve, precision, accuracy, robus-
tness, selectivity, and detection and quantification limits 
(Hubert et al., 2007a,b; Rozet et al., 2007a; Brasil, 2003; 
FDA, 2001; ICH, 1996).
Calibration curve
The calibration curve was obtained using five re-
ference standard concentrations (5.00, 7.50, 11.3, 16.9, 
and 25.3 μg/mL), whose assays were performed on four 
different days.
Precision
Precision of the method was determined by repe-
atability (intra-assay) and intermediate precision (inter-
assay). Repeatability was assessed, in triplicate, through 
the assay of solutions at concentrations of 2.50, 5.00, and 
10.0 μg/mL (50%); 5.00, 10.0, and 20.0 μg/mL (100%); 
and 7.50, 15.0, and 30.0 μg/mL (150%) for the 3x3 design 
and in quintuplicate of solutions at concentrations of 5.00, 
11.3, and 25.3 μg/mL for the 5x1 design, all on the same 
day. Intermediate precision was verified by evaluating the 
results on two different days.
Accuracy
Accuracy was determined by means of microbio-
logical assay, in quintuplicate, of the reference standard 
solutions at concentrations of 5.00, 11.3, and 25.3 μg/mL 
for the 5x1 design. For the 3x3 design, reference standard 
solutions at concentrations of 2.50, 5.00, and 10.0 μg/mL 
(50%); 5.00, 10.0, and 20.0 μg/mL (100%); and 7.50, 15.0, 
and 30.0 μg/mL (150%) were assayed in triplicate. The 
assays were performed on two different days.
Selectivity
To prove that the microbiological assay was selecti-
ve, the analyte was submitted to the hydrolysis conditions 
described by Ishii and Witkop (1964). The degradation 
product was assayed using the high performance liquid 
chromatography (HPLC) method to test for the compo-
sition specified in British Pharmacopoeia (2007) and by 
the microbiological method using the two designs (3x3 
and 5x1). The HPLC analyses were carried out on an 
Agilent 1200 system, using a C-18 reversed-phase colu-
mn (250 x 4.6 mm i.d. and 5 μm particle size), a flow rate 
of 1.0 ml/min, a mixture of methanol and water (29:71) 
as mobile phase, and detection wavelength of 282 nm. 
The run time was 2.5 times (90 min) the retention time 
of gramicidin A1 (about 36 min) (British Pharmacopeia, 
2007). For the microbiological assay, degradation product 
solutions at concentrations of 5.00, 10.0, and 20.0 μg/mL 
(3x3) and 11.3 μg/mL (5x1) were prepared in polysorbate 
80 at 1%, assayed in comparison with the diluent 
and the reference standard solutions (5.00, 10.0, and 
20.0 μg/mL for 3x3 and 5.00, 7.50, 11.3, 16.9, and 
25.3 μg/mL for 5x1).
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Limits of Detection and Quantification
To determine the detection and lower quantification 
limits, reference standard solutions at concentrations 1.00, 
2.00, 3.00, and 4.00 μg/mL and the diluent were assayed 
by the 5x1 design. The upper quantification limit was 
determined using the 5x1 design with reference standard 
solutions at concentrations of 28.0, 30.0, and 32.0 μg/mL. 
The assays were carried out on two different days.
Robustness
To evaluate robustness, reference standard solutions 
at concentrations 5.00, 7.50, 11.3, 16.9, and 25.3 μg/mL 
were assayed in nutrient agar with a pH adjusted to 6 and 
8, and on plates with a base layer consisting of either an-
tibiotic medium 1 or a culture medium of the same com-
position as nutrient agar substituting the gelatin peptone 
for tryptone, casamine, or lactalbumin.
Statistical analysis
The analysis of variance (ANOVA) was used to 
compare the results obtained under the different conditions 
tested, such as the selection of the test microorganism, 
concentration of the inoculum, use of different diluents, 
and different concentration of gramicidin, to determine 
the detection and quantification limits. The Bonferroni 
test was used as a test of averages.
The calibration curves constructed were assessed 
through residue analysis (homoscedasticity, normality, 
and independence of residues) and linear regression 
analysis using the ordinal least squares method (Souza, 
Junqueira, 2005; Finney, 1978). The analysis of covariance 
(ANCOVA) was used to compare the calibration curves 
obtained on different days to assess linearity as well as 
under the different conditions tested for the robustness 
parameter (Snedecor, Cochran, 1996). 
To calculate the potency of the raw material gra-
micidin by the 3x3 design, the Hewitt equation was used 
(Hewitt, 2004). The assay was tested statistically using 
the parallel linear model, residue analysis, and linear 
regression analysis. The ANOVA test was used to verify 
the validity of the assay (Souza, Junqueira, 2005; Finney, 
1978). 
For the 5x1 design, the equation below was applied 
to correct the growth inhibition:
–yPcj = 
–yPj + (=yP3 – 
–yP3j);
in which –yPcj is the corrected average of the zone diameter 
of growth inhibition corresponding to the concentration 
present on the j plate; –yPj is the average of the zone diame-
ter of growth inhibition corresponding to the concentration 
present on the j plate; =yP3 is the average of all the averages 
of the zone diameter of growth inhibition corresponding 
to the concentration of 11.3 μg/mL; –yP3j is the average of 
the zone diameter of growth inhibition corresponding to 
the concentration of 11.3 μg/mL present on the j plate. 
Three corrected averages of the zone diameter of growth 
inhibition were obtained for each concentration, not in-
cluding the reference concentration (11.3 μg/mL), which 
was used for the correction. To calculate the potency of 
the raw material gramicidin, the Hewitt equation was used 
(Hewitt, 2004). The assay was analyzed statistically using 
residue analysis and linear regression analysis (Souza, 
Junqueira, 2005; Finney, 1978). The significance level for 
all the analyses was α = 0.05.
RESULTS AND DISCUSSION
K. rhizophila ATCC 9341 was the strain chosen as 
the test microorganism because it produced a larger and 
clearer zone diameter of growth inhibition than the other 
tested microorganisms: S. aureus ATCC 6538, E. hirae 
ATCC 10541 and S. epidermidis ATCC 12228.
Gramicidin has poor water solubility and low diffu-
sibility, aspects which stem from its chemical structure. 
It contains the terminal N and C groups, linked to the 
formyl and ethanolamine groups, respectively. Hence, 
gramicidin is uncharged at all pH values, which explains 
its low solubility in water (Koo et al., 2001). In addition, 
it possesses a high molecular weight. These properties 
justify the low diffusibility of the molecule in solid culture 
medium, thus generating small zones of growth inhibition 
(Viola, Canestrini, 1966).
Many conditions were tested with the objective of 
obtaining larger zones, such as different diluents for the 
preparation of solutions, culture media, and the concentra-
tion of the inoculum. More optimal results were obtained 
when the nutrient agar was used as the culture medium and 
an aqueous solution of polysorbate 80 at 1% was used as 
the diluent, preparing the gramicidin solutions within the 
range 5.00 to 25.3 μg/mL and the inoculum at 0.1% of K. 
rhizophila. Within this concentration interval, the regression 
between the logarithm of the concentration and the zone 
diameter of growth inhibition was considered significant. 
The linear model proved to be adequate as it could be proven 
that the residues followed a normal distribution pattern and 
were independent, i.e. homoscedasticity was observed and 
lack of fit was not significant. The calibration curve was 
obtained through the 5x1 experimental design; therefore, the 
mean of the corrected averages of zone diameter of growth 
inhibition (mm) for the reference standard solutions was: 
10.60 (R.S.D. 1.85%) for the concentration of 5.00 μg/mL; 
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11.18 (R.S.D. 0.54%) for 7.50 μg/mL; 11.75 (R.S.D. 1.13%) 
for 11.3 μg/mL; 12.35 (R.S.D. 1.05%) for 16.9 μg/mL, and 
13.07 (R.S.D. 0.29%) for 25.3 μg/mL. Five calibration cur-
ves were constructed (Table I), two on the same day and the 
remainder on different days. All presented a coefficient of 
correlation (r) greater than 0.98 (Brasil, 2003; FDA, 2001) 
and when compared, no significant difference was found 
between the intercepts and slopes.
The 3x3 design assay proved to be valid for the 
concentrations 5.00, 10.0, and 20.0 μg/mL, inserted wi-
thin the linear range 5.00 to 25.3 μg/mL. No deviation 
of parallelism or significant curvatures was observed. In 
addition, the residue analysis for both the standard’s and 
sample’s curves demonstrated that the linear model was 
appropriate for both.
The repeatability (intra-assay) and intermediate 
precision (inter-assays) were expressed as the relative 
standard deviation of a series of measures. The results are 
shown in Table II. The relative deviations were well below 
15% for all levels of concentrations tested, thus indicating 
appropriate intra- and inter-assay precision (Brasil, 2003; 
FDA, 2001).
According to the trueness parameter, there was no 
evidence indicating systematic errors in either experi-
mental design (Hubert et al., 2007a; Rozet et al., 2007a; 
INMETRO, 2003). Upon plotting the potencies determi-
ned experimentally vs. the theoretical value, a line was 
obtained. The experimental values were approximate to 
the true values, thus the line did not shift away from the 
ideal line, in which the intercept was equal to zero and 
the slope was equal to one, in turn proving the absence of 
systemic errors (Rozet et al., 2007a; INMETRO, 2003).
The method had appropriate accuracy, as can be 
seen by the values calculated for the β tolerance interval 
(Figure 1) for each concentration level, which showed a 
maximum variation of 15% for both designs (Hubert et al., 
2007a, b;  Rozet et al., 2007a; FDA, 2001). Accuracy is 
represented by the combination of the random (precision) 
and systematic (trueness) errors, which were considered 
in the β tolerance interval calculation. This represents the 
interval in which β% of the future individual results is 
expected (Rozet et al., 2007b).
The method proved to be selective for gramicidin as 
the degradation product assayed by the microbiological 
method showed only local activity at the tested concen-
trations, with no significant difference between the zone 
diameter of growth inhibition of the different concentra-
tions and that of the diluent. In addition, the degradation of 
gramicidin was proven by the absence of the characteristic 
peaks of the antibiotic within the chromatogram of the 
degradation product (Figure 2).
To determine the limit of detection, upon comparing 
the zone diameter of growth inhibition of the different con-
TABLE I - Parameters of calibration curve (intercept – a, slope – 
b, coefficient of correlation – r, and coefficient of determination 
- r2) for gramicidin within the range 5.00 to 25.3 µg/mL
Lines a ± SD b ± SD r r2
Day 1 Aa 8.00 ± 0.10 3.59 ± 0.09 0.997 0.994
Day 1 Ba 8.00 ± 0.22 3.55 ± 0.21 0.984 0.967
Day 2 7.74 ± 0.24 3.81 ± 0.21 0.985 0.969
Day 3 7.83 ± 0.16 3.60 ± 0.14 0.991 0.983
Day 4 8.26 ± 0.24 3.35 ± 0.22 0.98 0.956
aLines 1A and 1B were obtained on the same day, while 2, 3, 
and 4 were obtained on different days.
TABLE II - Results of potency of solutions of different concentrations of gramicidin determined by agar diffusion method to study 
precision and accuracy
Replicates
5x1 Design 3x3 Design
5.00 µg/mL 11.3 µg/mL 25.3 µg/mL 50% 100% 150%
1
2
3
4
5
5.37
5.30
5.21
5.17
4.97
11.10
11.59
11.33
11.09
11.40
25.26
25.13
24.93
25.02
25.11
51.99
50.12
48.30
101.40
101.76
102.97
152.05
148.03
149.76
1
2
3
4
5
5.25
4.96
5.25
5.42
5.11
11.75
11.34
10.96
11.71
10.94
25.71
25.98
25.09
25.54
25.35
47.68
52.64
50.38
102.72
99.44
100.30
159.75
147.16
148.36
Intra-assay average 2.96 1.90 0.49 3.68 0.81 1.34
Inter-assay RSD 2.94 2.64 1.33 3.90 1.35 3.10
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FIGURE 2 - Chromatogram obtained through analysis of raw material (A) and degradation product (B) of gramicidin using HPLC 
method.
FIGURE 1 - Accuracy profile obtained for method of microbiological dosage of gramicidin using 3x3 and 5x1 designs. Dashed 
lines represent acceptance limits (-15%, 15%), whereas dotted lines represent 95% tolerance interval reached. When tolerance 
intervals are included in acceptance limits, the assay can be quantified accurately.
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centrations of gramicidin (1.00, 2.00, 3.00 e 4.00 μg/mL) 
and of the diluent, a significant difference was found be-
tween them. It was shown that the lowest concentration 
to produce a zone diameter of growth inhibition different 
to that of the diluent was 2.00 μg/mL. This value was 
thus considered the limit of detection. The results for the 
potency of the concentrations 2.00, 3.00, 4.00, 28.0, 30.0, 
and 32.0 μg/mL were neither precise nor accurate. Never-
theless, satisfactory results were obtained when using the 
concentrations 5.00 and 25.3 μg/mL (Table II), determined 
as the upper and lower quantification limits, respectively.
A parallelism between the lines obtained when using 
the nutrient agar with a pH of 6, 7, and 8 was evident. 
However, a reduction in the zone diameter of growth 
inhibition was seen within the pH conditions of 6 and 8. 
A similar result was obtained when antibiotic medium 1 
was used as a base layer. Upon using other media as base 
layers, no growth of the test microorganism was observed. 
Therefore, the pH conditions and composition of the me-
dium should be controlled.
The experimental values for the potency of grami-
cidin in the sample are given in Table III. The combined 
potency for the 3x3 design was 105.37%, whereas for the 
5x1 design was 105.22%, with an estimated confidence 
interval at 95% ranging from 102.34% to 108.49% and 
102.27% to 108.25%, respectively. Such results are wi-
thin pharmacopoeic specifications for the potency limit 
(900 μg/mg) and confidence limit (± 5%), thus proving 
that the method produced appropriate and precise results 
(British Pharmacopoeia, 2007).
The precision of the designs was compared, and no 
significant difference was found.
CONCLUSION
These results indicated that the microbiological as-
say of the cylinder-plate method offered good precision, 
accuracy, selectivity, as well as an appropriate calibration 
curve in the concentration range of 5.00 to 25.3 μg/mL. 
Therefore, this method can be used to quantify the activity 
of the raw material gramicidin.
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